Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 77 entries
Sorted by: Best Match Show Resources per page
A simple, sensitive, and accurate alcohol electrode.

Biotechnology and bioengineering

Verduyn C, Van Dijken JP, Scheffers WA.
PMID: 18548718
Biotechnol Bioeng. 1983 Apr;25(4):1049-55. doi: 10.1002/bit.260250413.

The construction and performance of an enzyme electrode is described which specifically detects lower primary aliphatic alcohols in aqueous solutions. The electrode consists of a commercial Clark-type oxygen electrode on which alcohol oxidase (E.C. 1.1.3.13) and catalase were immobilized....

Cite
Verduyn C, Van Dijken JP, Scheffers WA. A simple, sensitive, and accurate alcohol electrode. Biotechnol Bioeng. 1983;25(4):1049-55doi: 10.1002/bit.260250413.
Verduyn, C., Van Dijken, J. P., & Scheffers, W. A. (1983). A simple, sensitive, and accurate alcohol electrode. Biotechnology and bioengineering, 25(4), 1049-55. https://doi.org/10.1002/bit.260250413
Verduyn, C, et al. "A simple, sensitive, and accurate alcohol electrode." Biotechnology and bioengineering vol. 25,4 (1983): 1049-55. doi: https://doi.org/10.1002/bit.260250413
Verduyn C, Van Dijken JP, Scheffers WA. A simple, sensitive, and accurate alcohol electrode. Biotechnol Bioeng. 1983 Apr;25(4):1049-55. doi: 10.1002/bit.260250413. PMID: 18548718.
Copy Download .nbib Format: NLM
Indications for cerebral revascularization for patients with atherosclerotic carotid occlusion.

Skull base : official journal of North American Skull Base Society ... [et al.]

Derdeyn CP, Grubb RL, Powers WJ.
PMID: 16148980
Skull Base. 2005 Feb;15(1):7-14. doi: 10.1055/s-2005-868159.

Patients with complete carotid occlusion and recent ischemic symptoms are at high risk for subsequent stroke, particularly those with evidence of severe hemodynamic impairment due to poor collateral flow. Treatment options for these patients include direct extracranial to intracranial...

Cite
Derdeyn CP, Grubb RL, Powers WJ. Indications for cerebral revascularization for patients with atherosclerotic carotid occlusion. Skull Base. 2005;15(1):7-14doi: 10.1055/s-2005-868159.
Derdeyn, C. P., Grubb, R. L., & Powers, W. J. (2005). Indications for cerebral revascularization for patients with atherosclerotic carotid occlusion. Skull base : official journal of North American Skull Base Society ... [et al.], 15(1), 7-14. https://doi.org/10.1055/s-2005-868159
Derdeyn, Colin P, et al. "Indications for cerebral revascularization for patients with atherosclerotic carotid occlusion." Skull base : official journal of North American Skull Base Society ... [et al.] vol. 15,1 (2005): 7-14. doi: https://doi.org/10.1055/s-2005-868159
Derdeyn CP, Grubb RL, Powers WJ. Indications for cerebral revascularization for patients with atherosclerotic carotid occlusion. Skull Base. 2005 Feb;15(1):7-14. doi: 10.1055/s-2005-868159. PMID: 16148980; PMCID: PMC1151700.
Copy Download .nbib Format: NLM
Growth, fatty acid profile in major lipid classes and lipid fluidity of Aurantiochytrium mangrovei SK-02 As a function of growth temperature.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]

Chodchoey K, Verduyn C.
PMID: 24031817
Braz J Microbiol. 2012 Jan;43(1):187-200. doi: 10.1590/S1517-838220120001000020. Epub 2012 Jun 01.

Aurantiochytrium mangrovei Sk-02 was grown in a medium containing glucose (40 g/l), yeast extract (10 g/L) and sea salts (15 g/L) at temperatures ranging from 12 to 35°C. The fastest growth (µmax= 0.15 h(-1)) and highest fatty acid content...

Cite
Chodchoey K, Verduyn C. Growth, fatty acid profile in major lipid classes and lipid fluidity of Aurantiochytrium mangrovei SK-02 As a function of growth temperature. Braz J Microbiol. 2012;43(1):187-200doi: 10.1590/S1517-838220120001000020.
Chodchoey, K., & Verduyn, C. (2012). Growth, fatty acid profile in major lipid classes and lipid fluidity of Aurantiochytrium mangrovei SK-02 As a function of growth temperature. Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 43(1), 187-200. https://doi.org/10.1590/S1517-838220120001000020
Chodchoey, Kanokwan, and Verduyn, Cornelis. "Growth, fatty acid profile in major lipid classes and lipid fluidity of Aurantiochytrium mangrovei SK-02 As a function of growth temperature." Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] vol. 43,1 (2012): 187-200. doi: https://doi.org/10.1590/S1517-838220120001000020
Chodchoey K, Verduyn C. Growth, fatty acid profile in major lipid classes and lipid fluidity of Aurantiochytrium mangrovei SK-02 As a function of growth temperature. Braz J Microbiol. 2012 Jan;43(1):187-200. doi: 10.1590/S1517-838220120001000020. Epub 2012 Jun 01. PMID: 24031817; PMCID: PMC3768996.
Copy Download .nbib Format: NLM
Treatment options for high-risk chronic lymphocytic leukaemia.

Therapeutic advances in hematology

Hewamana S, Dearden C.
PMID: 23556086
Ther Adv Hematol. 2011 Jun;2(3):147-59. doi: 10.1177/2040620711404469.

Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia in the Western world. The natural history of CLL is extremely variable with a survival time from initial diagnosis that ranges from 2 to more than 20 years....

Cite
Hewamana S, Dearden C. Treatment options for high-risk chronic lymphocytic leukaemia. Ther Adv Hematol. 2011;2(3):147-59doi: 10.1177/2040620711404469.
Hewamana, S., & Dearden, C. (2011). Treatment options for high-risk chronic lymphocytic leukaemia. Therapeutic advances in hematology, 2(3), 147-59. https://doi.org/10.1177/2040620711404469
Hewamana, Saman, and Dearden, Claire. "Treatment options for high-risk chronic lymphocytic leukaemia." Therapeutic advances in hematology vol. 2,3 (2011): 147-59. doi: https://doi.org/10.1177/2040620711404469
Hewamana S, Dearden C. Treatment options for high-risk chronic lymphocytic leukaemia. Ther Adv Hematol. 2011 Jun;2(3):147-59. doi: 10.1177/2040620711404469. PMID: 23556086; PMCID: PMC3573406.
Copy Download .nbib Format: NLM
Paving the Way for Therapy: The Second International Conference of the Trisomy 21 Research Society.

Molecular syndromology

Reeves RH, Delabar J, Potier MC, Bhattacharyya A, Head E, Lemere C, Dekker AD, De Deyn P, Caviedes P, Dierssen M, Busciglio J.
PMID: 30800043
Mol Syndromol. 2019 Jan;9(6):279-286. doi: 10.1159/000494231. Epub 2018 Oct 30.

In the last decade, a number of important research advances in different fields have allowed Down syndrome (DS) research to flourish, creating a time of both unparalleled opportunity and considerable challenge. Building a scientific framework that distills mechanisms involved...

Cite
Reeves RH, Delabar J, Potier MC, et al. Paving the Way for Therapy: The Second International Conference of the Trisomy 21 Research Society. Mol Syndromol. 2018;9(6):279-286doi: 10.1159/000494231.
Reeves, R. H., Delabar, J., Potier, M. C., Bhattacharyya, A., Head, E., Lemere, C., Dekker, A. D., De Deyn, P., Caviedes, P., Dierssen, M., & Busciglio, J. (2019). Paving the Way for Therapy: The Second International Conference of the Trisomy 21 Research Society. Molecular syndromology, 9(6), 279-286. https://doi.org/10.1159/000494231
Reeves, Roger H, et al. "Paving the Way for Therapy: The Second International Conference of the Trisomy 21 Research Society." Molecular syndromology vol. 9,6 (2019): 279-286. doi: https://doi.org/10.1159/000494231
Reeves RH, Delabar J, Potier MC, Bhattacharyya A, Head E, Lemere C, Dekker AD, De Deyn P, Caviedes P, Dierssen M, Busciglio J. Paving the Way for Therapy: The Second International Conference of the Trisomy 21 Research Society. Mol Syndromol. 2019 Jan;9(6):279-286. doi: 10.1159/000494231. Epub 2018 Oct 30. PMID: 30800043; PMCID: PMC6381890.
Copy Download .nbib Format: NLM
A Clinician's Guide to Think Good-Feel Good: Using CBT with Children and Young People.

Child and adolescent mental health

Verduyn C.
PMID: 32811126
Child Adolesc Ment Health. 2007 May;12(2):102. doi: 10.1111/j.1475-3588.2007.00450_9.x.

No abstract available.

Cite
Verduyn C. A Clinician's Guide to Think Good-Feel Good: Using CBT with Children and Young People. Child Adolesc Ment Health. 2007;12(2):102doi: 10.1111/j.1475-3588.2007.00450_9.x.
Verduyn, C. (2007). A Clinician's Guide to Think Good-Feel Good: Using CBT with Children and Young People. Child and adolescent mental health, 12(2), 102. https://doi.org/10.1111/j.1475-3588.2007.00450_9.x
Verduyn, Chrissie. "A Clinician's Guide to Think Good-Feel Good: Using CBT with Children and Young People." Child and adolescent mental health vol. 12,2 (2007): 102. doi: https://doi.org/10.1111/j.1475-3588.2007.00450_9.x
Verduyn C. A Clinician's Guide to Think Good-Feel Good: Using CBT with Children and Young People. Child Adolesc Ment Health. 2007 May;12(2):102. doi: 10.1111/j.1475-3588.2007.00450_9.x. PMID: 32811126.
Copy Download .nbib Format: NLM
Dural arteriovenous fistulas without cortical venous drainage: presentation, treatment, and outcomes.

Journal of neurosurgery

Samaniego EA, Roa JA, Hayakawa M, Chen CJ, Sheehan JP, Kim LJ, Abecassis IJ, Levitt MR, Guniganti R, Kansagra AP, Lanzino G, Giordan E, Brinjikji W, Bulters D, Durnford A, Fox WC, Polifka AJ, Gross BA, Amin-Hanjani S, Alaraj A, Kwasnicki A, Starke RM, Sur S, van Dijk JMC, Potgieser ARE, Satomi J, Tada Y, Abla A, Winkler E, Du R, Lai PMR, Zipfel GJ, Derdeyn CP.
PMID: 34507278
J Neurosurg. 2021 Sep 10;1-9. doi: 10.3171/2021.1.JNS202825. Epub 2021 Sep 10.

OBJECTIVE: Current evidence suggests that intracranial dural arteriovenous fistulas (dAVFs) without cortical venous drainage (CVD) have a benign clinical course. However, no large study has evaluated the safety and efficacy of current treatments and their impact over the natural...

Cite
Samaniego EA, Roa JA, Hayakawa M, et al. Dural arteriovenous fistulas without cortical venous drainage: presentation, treatment, and outcomes. J Neurosurg. 2021;1-9doi: 10.3171/2021.1.JNS202825.
Samaniego, E. A., Roa, J. A., Hayakawa, M., Chen, C. J., Sheehan, J. P., Kim, L. J., Abecassis, I. J., Levitt, M. R., Guniganti, R., Kansagra, A. P., Lanzino, G., Giordan, E., Brinjikji, W., Bulters, D., Durnford, A., Fox, W. C., Polifka, A. J., Gross, B. A., Amin-Hanjani, S., Alaraj, A., Kwasnicki, A., Starke, R. M., Sur, S., van Dijk, J. M. C., Potgieser, A. R. E., Satomi, J., Tada, Y., Abla, A., Winkler, E., Du, R., Lai, P. M. R., Zipfel, G. J., & Derdeyn, C. P. (2021). Dural arteriovenous fistulas without cortical venous drainage: presentation, treatment, and outcomes. Journal of neurosurgery, 1-9. https://doi.org/10.3171/2021.1.JNS202825
Samaniego, Edgar A, et al. "Dural arteriovenous fistulas without cortical venous drainage: presentation, treatment, and outcomes." Journal of neurosurgery vol. (2021): 1-9. doi: https://doi.org/10.3171/2021.1.JNS202825
Samaniego EA, Roa JA, Hayakawa M, Chen CJ, Sheehan JP, Kim LJ, Abecassis IJ, Levitt MR, Guniganti R, Kansagra AP, Lanzino G, Giordan E, Brinjikji W, Bulters D, Durnford A, Fox WC, Polifka AJ, Gross BA, Amin-Hanjani S, Alaraj A, Kwasnicki A, Starke RM, Sur S, van Dijk JMC, Potgieser ARE, Satomi J, Tada Y, Abla A, Winkler E, Du R, Lai PMR, Zipfel GJ, Derdeyn CP. Dural arteriovenous fistulas without cortical venous drainage: presentation, treatment, and outcomes. J Neurosurg. 2021 Sep 10;1-9. doi: 10.3171/2021.1.JNS202825. Epub 2021 Sep 10. PMID: 34507278.
Copy Download .nbib Format: NLM
Patients' satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors.

Journal of patient-reported outcomes

Darden C, Price M, Ray D, Goldstein G, Goss D, Bennett L, Garbinsky D, Thota R.
PMID: 34491454
J Patient Rep Outcomes. 2021 Sep 07;5(1):82. doi: 10.1186/s41687-021-00355-5.

BACKGROUND: Long-acting somatostatin analogs (LA SSAs) are approved and recommended for the treatment of patients with advanced neuroendocrine tumors (NETs). Given the long duration of therapy and differences in administration routes, it is important to understand patients' experiences with...

Cite
Darden C, Price M, Ray D, et al. Patients' satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors. J Patient Rep Outcomes. 2021;5(1):82doi: 10.1186/s41687-021-00355-5.
Darden, C., Price, M., Ray, D., Goldstein, G., Goss, D., Bennett, L., Garbinsky, D., & Thota, R. (2021). Patients' satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors. Journal of patient-reported outcomes, 5(1), 82. https://doi.org/10.1186/s41687-021-00355-5
Darden, Christina, et al. "Patients' satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors." Journal of patient-reported outcomes vol. 5,1 (2021): 82. doi: https://doi.org/10.1186/s41687-021-00355-5
Darden C, Price M, Ray D, Goldstein G, Goss D, Bennett L, Garbinsky D, Thota R. Patients' satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors. J Patient Rep Outcomes. 2021 Sep 07;5(1):82. doi: 10.1186/s41687-021-00355-5. PMID: 34491454; PMCID: PMC8423948.
Copy Download .nbib Format: NLM
The prognostic value of bispectral index and suppression ratio monitoring after out-of-hospital cardiac arrest: a prospective observational study.

Annals of intensive care

Eertmans W, Genbrugge C, Vander Laenen M, Boer W, Mesotten D, Dens J, Jans F, De Deyne C.
PMID: 29500559
Ann Intensive Care. 2018 Mar 02;8(1):34. doi: 10.1186/s13613-018-0380-z.

BACKGROUND: We investigated the ability of bispectral index (BIS) monitoring to predict poor neurological outcome in out-of-hospital cardiac arrest (OHCA) patients fully treated according to guidelines.RESULTS: In this prospective, observational study, 77 successfully resuscitated OHCA patients were enrolled in...

Cite
Eertmans W, Genbrugge C, Vander Laenen M, et al. The prognostic value of bispectral index and suppression ratio monitoring after out-of-hospital cardiac arrest: a prospective observational study. Ann Intensive Care. 2018;8(1):34doi: 10.1186/s13613-018-0380-z.
Eertmans, W., Genbrugge, C., Vander Laenen, M., Boer, W., Mesotten, D., Dens, J., Jans, F., & De Deyne, C. (2018). The prognostic value of bispectral index and suppression ratio monitoring after out-of-hospital cardiac arrest: a prospective observational study. Annals of intensive care, 8(1), 34. https://doi.org/10.1186/s13613-018-0380-z
Eertmans, Ward, et al. "The prognostic value of bispectral index and suppression ratio monitoring after out-of-hospital cardiac arrest: a prospective observational study." Annals of intensive care vol. 8,1 (2018): 34. doi: https://doi.org/10.1186/s13613-018-0380-z
Eertmans W, Genbrugge C, Vander Laenen M, Boer W, Mesotten D, Dens J, Jans F, De Deyne C. The prognostic value of bispectral index and suppression ratio monitoring after out-of-hospital cardiac arrest: a prospective observational study. Ann Intensive Care. 2018 Mar 02;8(1):34. doi: 10.1186/s13613-018-0380-z. PMID: 29500559; PMCID: PMC5834415.
Copy Download .nbib Format: NLM
[No title available]

AJNR. American journal of neuroradiology

Nagpal P, Policeni BA, Kwofie M, Bathla G, Derdeyn CP, Skeete D.
PMID: 30093481
AJNR Am J Neuroradiol. 2018 Sep;39(9):E104. doi: 10.3174/ajnr.A5758. Epub 2018 Aug 09.

No abstract available.

Cite
Nagpal P, Policeni BA, Kwofie M, et al. . AJNR Am J Neuroradiol. 2018;39(9):E104doi: 10.3174/ajnr.A5758.
Nagpal, P., Policeni, B. A., Kwofie, M., Bathla, G., Derdeyn, C. P., & Skeete, D. (2018). . AJNR. American journal of neuroradiology, 39(9), E104. https://doi.org/10.3174/ajnr.A5758
Nagpal, P, et al. "." AJNR. American journal of neuroradiology vol. 39,9 (2018): E104. doi: https://doi.org/10.3174/ajnr.A5758
Nagpal P, Policeni BA, Kwofie M, Bathla G, Derdeyn CP, Skeete D. . AJNR Am J Neuroradiol. 2018 Sep;39(9):E104. doi: 10.3174/ajnr.A5758. Epub 2018 Aug 09. PMID: 30093481; PMCID: PMC7655277.
Copy Download .nbib Format: NLM
Metabolic networks and bioenergetics of Aurantiochytrium sp. B-072 during storage lipid formation.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]

Chaisawang M, Verduyn C, Chauvatcharin S, Suphantharika M.
PMID: 24031944
Braz J Microbiol. 2012 Jul;43(3):1192-205. doi: 10.1590/S1517-838220120003000047. Epub 2012 Jun 01.

Baffled shake flask cultivation of Aurantiochytrium sp. B-072 was carried out at in a glucose-monosodium glutamate mineral medium at different C/N-ratios (30-165) with glucose fixed at 90 g/L. With increasing C/N-ratio, a modest increase in lipid content (60 to...

Cite
Chaisawang M, Verduyn C, Chauvatcharin S, et al. Metabolic networks and bioenergetics of Aurantiochytrium sp. B-072 during storage lipid formation. Braz J Microbiol. 2012;43(3):1192-205doi: 10.1590/S1517-838220120003000047.
Chaisawang, M., Verduyn, C., Chauvatcharin, S., & Suphantharika, M. (2012). Metabolic networks and bioenergetics of Aurantiochytrium sp. B-072 during storage lipid formation. Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 43(3), 1192-205. https://doi.org/10.1590/S1517-838220120003000047
Chaisawang, Montri, et al. "Metabolic networks and bioenergetics of Aurantiochytrium sp. B-072 during storage lipid formation." Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] vol. 43,3 (2012): 1192-205. doi: https://doi.org/10.1590/S1517-838220120003000047
Chaisawang M, Verduyn C, Chauvatcharin S, Suphantharika M. Metabolic networks and bioenergetics of Aurantiochytrium sp. B-072 during storage lipid formation. Braz J Microbiol. 2012 Jul;43(3):1192-205. doi: 10.1590/S1517-838220120003000047. Epub 2012 Jun 01. PMID: 24031944; PMCID: PMC3768889.
Copy Download .nbib Format: NLM
Stage C or not stage C...?.

Blood

Dearden C.
PMID: 21127179
Blood. 2010 Dec 02;116(23):4735-6. doi: 10.1182/blood-2010-09-305375.

No abstract available.

Cite
Dearden C. Stage C or not stage C...?. Blood. 2010;116(23):4735-6doi: 10.1182/blood-2010-09-305375.
Dearden, C. (2010). Stage C or not stage C...?. Blood, 116(23), 4735-6. https://doi.org/10.1182/blood-2010-09-305375
Dearden, Claire. "Stage C or not stage C...?." Blood vol. 116,23 (2010): 4735-6. doi: https://doi.org/10.1182/blood-2010-09-305375
Dearden C. Stage C or not stage C...?. Blood. 2010 Dec 02;116(23):4735-6. doi: 10.1182/blood-2010-09-305375. PMID: 21127179.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 77 entries